BIOMARIN PHARMACEUTICAL INCBIOMARIN PHARMACEUTICAL INCBIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
5.66MXN
Revenue estimate
‪11.22 B‬MXN
Market capitalization
‪265.88 B‬MXN
‪2.85 B‬MXN
‪41.09 B‬MXN
‪186.04 M‬
Beta (1Y)
0.25

About BioMarin Pharmaceutical Inc.

CEO
Alexander Hardy
Headquarters
San Rafael
Employees (FY)
‪3.4 K‬
Founded
1997
FIGI
BBG00PG3KTH6
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where BMRN is featured.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BIOMARIN PHARMACEUTICAL INC stocks are traded under the ticker BMRN.
BIOMARIN PHARMACEUTICAL INC is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
BMRN stock is 0.46% volatile and has beta coefficient of 0.25. Track BIOMARIN PHARMACEUTICAL INC stock price on the chart and check out the list of the most volatile stocks — is BIOMARIN PHARMACEUTICAL INC there?
BMRN earnings for the last quarter are 1.87 MXN per share, whereas the estimation was 3.35 MXN resulting in a −44.21% surprise. The estimated earnings for the next quarter are 5.17 MXN per share. See more details about BIOMARIN PHARMACEUTICAL INC earnings.
BIOMARIN PHARMACEUTICAL INC revenue for the last quarter amounts to ‪10.98 B‬ MXN despite the estimated figure of ‪10.85 B‬ MXN. In the next quarter revenue is expected to reach ‪10.80 B‬ MXN.
Yes, you can track BIOMARIN PHARMACEUTICAL INC financials in yearly and quarterly reports right on TradingView.
BMRN stock has fallen by 0.45% compared to the previous week, the month change is a 0.45% fall, over the last year BIOMARIN PHARMACEUTICAL INC has showed a 0.45% decrease.
BMRN net income for the last quarter is ‪1.47 B‬ MXN, while the quarter before that showed ‪346.07 M‬ MXN of net income which accounts for 324.59% change. Track more BIOMARIN PHARMACEUTICAL INC financial stats to get the full picture.
Today BIOMARIN PHARMACEUTICAL INC has the market capitalization of ‪265.88 B‬, it has increased by 1.77% over the last week.
No, BMRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BMRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 5, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL INC on this list?
We've gathered analysts' opinions on BIOMARIN PHARMACEUTICAL INC future price: according to them, BMRN price has a max estimate of 2380.63 MXN and a min estimate of 1360.36 MXN. Watch BMRN chart and read a more detailed BIOMARIN PHARMACEUTICAL INC stock forecast: see what analysts think of BIOMARIN PHARMACEUTICAL INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL INC EBITDA is ‪5.37 B‬ MXN, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL INC financial statements.